BamSEC and AlphaSense Join Forces
Learn More

Iovance Biotherapeutics Inc.

NASDAQ: IOVA    
Share price (12/20/24): $7.38    
Market cap (12/20/24): $2.249 billion

Indentures Filter

EX-4.1
from S-3ASR 64 pages Iovance Biotherapeutics, Inc. Indenture Dated as of [·] [·] Trustee
12/34/56
EX-4.1
from S-3ASR 53 pages Iovance Biotherapeutics, Inc. Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.3
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3 53 pages Iovance Biotherapeutics, Inc. Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.1
from S-3 53 pages Iovance Biotherapeutics, Inc. Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.2
from 10-K 2 pages Additional Abbreviations May Also Be Used Though Not in the Above List. for Value Received, Hereby Sell, Assign and Transfer Unto Please Insert Social Security or Other Identifying Number of Assignee
12/34/56
EX-4.1
from S-3 53 pages (Continued) Page
12/34/56
EX-4.1
from S-3 53 pages Lion Biotechnologies, Inc. Indenture Dated as of [●] [●] Trustee
12/34/56
EX-4.10
from S-8 7 pages Lion Biotechnologies, Inc. Option Certificate
12/34/56
EX-4.9
from S-8 7 pages Lion Biotechnologies, Inc. Option Certificate
12/34/56
EX-4.1
from S-3 59 pages Lion Biotechnologies, Inc. to [ ], as Trustee Indenture Dated as of , Lion Biotechnologies, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ,
12/34/56
EX-4.1
from 8-K 16 pages Lion Biotechnologies, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 10-K 7 pages Common Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 17 pages Common Stock Purchase Warrant Series B Warrant Genesis Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Series a Warrant Genesis Biopharma, Inc
12/34/56
EX-4.1
from 10-K 11 pages Genesis Biopharma, Inc. 2010 Equity Compensation Plan I. Establishment of Plan; Definitions
12/34/56